object
provid
feasibl
costeffect
nextgener
sequenc
ng
method
accur
identif
viral
pathogen
clinic
specimen
enorm
limit
imped
clinic
use
common
ng
high
cost
complic
procedur
tremend
data
analysi
high
background
nois
clinic
sampl
method
virus
cell
cultur
materi
clinic
specimen
identifi
follow
improv
ng
procedur
reduct
background
nois
sampl
preprocess
viral
enrich
barcod
oligonucleotid
random
hexam
nonribosom
hexanucleotid
primerbas
amplif
fragmentationfre
librari
construct
sequenc
onetub
mixtur
well
rapid
data
analysi
use
inhous
pipelin
result
ng
data
demonstr
barcod
primer
set
use
simultan
captur
multipl
viral
pathogen
cell
cultur
materi
clinic
specimen
verifi
hexanucleotid
primer
captur
mani
viral
sequenc
hexam
moreov
direct
test
clinic
specimen
use
improv
hexanucleotid
primerbas
ng
approach
provid
detail
genotyp
enterovirus
caus
hand
foot
mouth
diseas
hfmd
identifi
potenti
virus
differenti
misdiagnosi
event
improv
barcod
oligonucleotid
primerbas
ng
approach
simplifi
time
save
cost
effect
appropri
direct
identif
viral
pathogen
clinic
practic
irus
caus
seriou
health
problem
human
develop
develop
countri
particular
pathogen
virus
potenti
rapid
global
spread
high
morbid
mortal
last
year
centuri
wit
outbreak
signific
public
health
issu
caus
virus
sever
acut
respiratori
syndrom
coronaviru
sarscov
swineorigin
influenza
viru
avianorigin
influenza
viru
middl
east
respiratori
syndrom
merscov
ebola
viru
therefor
accur
identif
analysi
caus
agent
viral
infecti
diseas
extrem
urgent
crucial
activ
control
prevent
viru
spread
recent
year
nextgener
sequenc
ng
emerg
method
identif
viral
pathogen
requir
priori
knowledg
potenti
infecti
agent
power
tool
tradit
viral
diagnost
method
includ
electron
microscopi
cell
cultur
antigen
detect
nucleic
acid
detect
cytolog
histolog
serolog
multipl
virus
detect
simultan
novel
highli
diverg
virus
discov
genet
character
use
ng
howev
account
low
viru
abund
high
background
nois
clinic
specimen
clinic
applic
ng
viru
detect
still
limit
moreov
limit
rel
high
cost
librari
prepar
sequenc
complic
tediou
procedur
well
tremend
data
process
analysi
also
hinder
widespread
use
ng
clinic
practic
present
mani
way
increas
signaltonois
ratio
ratio
viral
genom
host
genom
ultracentrifug
filtrat
nucleas
treatment
sequenceindepend
amplif
like
random
pcr
combin
particularli
combin
method
centrifug
filtrat
nucleas
treatment
randompcr
rpcr
show
greatest
increas
proport
viral
sequenc
addit
rpcr
wide
use
effici
method
revers
transcript
perform
use
oligonucleotid
made
random
hexam
tag
known
sequenc
enrich
lowabund
viral
nucleic
acid
recent
substract
primer
set
name
nonribosom
hexanucleotid
hexanucleotid
design
reduc
nois
revers
transcript
viral
enrich
abil
verifi
cdna
represent
differ
analysi
rda
compar
random
hexam
ngsbase
evalu
viral
enrich
abil
random
hexam
hexanucleotid
yet
unreport
directli
pool
sampl
begin
without
barcod
pool
individu
librari
barcod
adaptor
ng
may
reduc
sequenc
cost
subsequ
verif
test
interest
sampl
pool
sampl
individu
librari
construct
pool
sampl
rather
labori
time
consum
addit
fragment
dna
rna
librari
alway
recommend
acquir
much
inform
origin
sampl
howev
shear
time
difficult
control
dna
rna
origin
sampl
differ
viru
abund
treatment
may
increas
occurr
artefactu
recombin
moreov
process
analysi
tremend
ng
data
alway
complex
time
consum
highli
depend
excel
profession
bioinformatician
impract
mani
laboratori
address
limit
present
studi
describ
simplifi
rapid
rel
costeffect
ng
approach
barcod
random
hexam
nonribosom
hexanucleotid
primer
use
revers
transcript
step
viral
enrich
follow
sampl
pool
enrich
product
one
tube
singl
sampl
fragmentationfre
librari
construct
sequenc
highthroughput
sequenc
data
rapidli
analyz
inhous
pipelin
demonstr
multipl
virus
accur
identifi
cell
cultur
materi
clinic
specimen
verifi
viral
enrich
abil
primer
set
nearli
compar
model
experi
sequenc
three
repres
virus
furthermor
direct
test
clinic
specimen
associ
hand
foot
mouth
diseas
hfmd
use
improv
hexanucleotid
primerbas
ng
approach
provid
detail
genotyp
viral
pathogen
identifi
potenti
virus
differenti
misdiagnosi
event
appear
clinic
clinic
specimen
thaw
follow
preprocess
reduc
background
nois
previous
publish
protocol
briefli
viral
transport
medium
vortex
thoroughli
centrifug
min
remov
debri
supernat
filter
filter
millipor
dispers
aliquot
detect
flu
b
ebv
realtim
rtpcr
perform
reaction
solut
contain
rna
dna
forward
revers
primer
flu
b
f
r
f
r
ebv
f
r
reagent
qpcr
master
mix
promega
thermal
cycl
paramet
revers
transcript
min
denatur
min
cycl
abi
fast
realtim
pcr
system
appli
biosystem
detect
clinic
specimen
patient
diagnos
sever
mild
hfmd
realtim
rtpcr
conduct
use
primer
pair
correspond
probe
hev
per
previous
publish
protocol
sampl
consid
posit
threshold
cycl
ct
valu
enrich
purifi
viral
nucleic
acid
conduct
use
modifi
rtpcr
method
briefli
viral
rna
mix
mmoll
dntp
pmol
random
hexam
hexanucleotid
tag
known
barcod
sequenc
aatcacataggcgtccgctg
b
ggca
ggacctctgatacagg
c
ggcactcgactcgtaaca
gg
gtctctgtcacgacggtcag
e
ggatagtcgg
cgtgcaccaa
f
aacacctctggaacacgccc
g
ggt
ccaggcacaatccagtc
h
acggtgtgttaccgacgt
cc
tgcgaaccgttacgggtgga
j
ggacaagcac
agcatagcca
use
viral
nucleic
acid
enrich
also
pool
demultiplex
sequenc
viral
librari
mixtur
heat
min
immedi
place
ice
firststrand
cdna
synthesi
perform
per
iii
revers
transcriptas
kit
invitrogen
manual
thereaft
second
strand
cdna
synthes
use
exo
klenow
fragment
new
england
biolab
follow
amplif
doublestrand
cdna
use
barcod
oligonucleotid
kapa
hifi
hot
start
readi
mix
pcr
kit
kapabiosystem
enrich
viral
content
pcr
program
includ
min
initi
denatur
cycl
final
extens
min
enrich
product
purifi
separ
use
minelut
reaction
cleanup
kit
qiagen
per
manufactur
specif
group
purifi
dna
sampl
pool
equal
mass
one
mixtur
librari
construct
figur
briefli
total
ng
ng
sampl
mixtur
use
input
place
endrepair
reaction
ion
plu
fragment
librari
kit
life
technolog
purifi
use
agencourt
ampur
bead
beckman
coulter
ion
torrent
sequenc
adaptor
ligat
end
pool
dna
follow
purif
appropri
volum
agencourt
ampur
bead
remov
adapt
dimer
bp
fraction
recycl
pool
dna
agaros
gel
invitrogen
subject
bioanalyz
analysi
use
highsensit
dna
kit
agil
technolog
qualifi
librari
quantifi
qpcr
use
ion
librari
quantif
kit
life
technolog
subsequ
subject
emulsionpcr
ion
templat
hiq
kit
life
technolog
es
enrich
ion
enrich
bead
life
technolog
recov
templateposit
ion
particl
load
onto
chip
sequenc
ion
torrent
sequenc
use
ion
torrent
hiq
sequenc
kit
life
technolog
raw
sequenc
data
sequenc
run
demultiplex
use
vendor
softwar
pgm
accord
barcod
sequenc
gener
individu
bam
file
sampl
file
contain
raw
sequenc
read
directli
process
analyz
inhous
viru
identif
pipelin
vip
biolinux
oper
environ
vip
recent
develop
laboratori
onetouch
comput
pipelin
viru
identif
discoveri
metagenom
ng
data
contribut
time
viru
diagnosi
min
perform
unbias
ng
data
program
run
accomplish
minut
gener
vip
report
includ
viru
popul
coverag
statist
certain
gene
complet
genom
viral
pathogen
correspond
averag
depth
sequenc
coverag
file
read
distribut
refer
viral
genom
three
repres
virusposit
flu
b
ebv
sampl
clinic
specimen
diagnos
sever
mild
hfmd
detect
realtim
rtpcr
result
show
cell
cultur
materi
sampl
confirm
posit
shown
tabl
ct
valu
ebv
sampl
respect
regard
flu
bposit
sampl
two
sampl
flu
flu
contain
slightli
high
viral
load
ct
valu
respect
wherea
third
one
flu
contain
low
viral
load
ct
valu
among
hfmd
clinic
specimen
sampl
found
posit
ct
valu
sampl
confirm
posit
enteroviru
ev
sampl
found
posit
human
enteroviru
hev
notabl
remain
four
sampl
test
neg
three
origin
sever
hfmd
case
one
origin
mild
hfmd
case
tabl
schemat
overview
viral
enrich
librari
construct
improv
ng
approach
viral
nucleic
acid
enrich
initi
perform
use
barcod
oligonucleotid
primer
nonribosom
hexanucleotid
random
hexam
revers
transcript
step
enrich
product
pool
togeth
one
tube
singl
sampl
subsequ
fragmentationfre
librari
construct
sequenc
evalu
feasibl
improv
ng
approach
three
repres
virusesposit
sampl
flu
b
ebv
describ
initi
select
sequenc
follow
modifi
procedur
figur
model
experi
meanwhil
viral
enrich
abil
hexanucleotid
primer
tradit
random
hexam
primer
compar
parallel
base
ng
data
viral
nucleic
acid
repres
virus
separ
prime
barcod
hexam
hexanucleotid
primer
firstand
secondstrand
cdna
synthesi
reaction
follow
amplif
doublestrand
cdna
use
oligonucleotid
barcod
thereaft
amplifi
product
pool
togeth
singl
sampl
fragmentationfre
librari
construct
sequenc
raw
sequenc
data
assign
back
origin
sampl
individu
accord
barcod
sequenc
total
read
individu
sampl
singl
run
rang
mean
read
length
vari
bp
bp
tabl
proport
virusrel
read
among
total
read
calcul
via
inhous
vip
result
show
ratio
virusrel
read
captur
hexanucleotid
primer
higher
captur
hexam
primer
rna
sampl
wherea
ratio
virusrel
read
captur
hexanucleotid
primer
slightli
lower
captur
hexam
primer
ebv
sampl
furthermor
shown
result
indic
improv
ng
method
accur
identifi
multipl
viral
pathogen
cell
cultur
materi
clinic
specimen
hexanucleotid
primerbas
ng
probabl
suitabl
clinic
viral
identif
view
sequenc
coverag
rna
dna
virus
confirm
hexanucleotid
primerbas
ng
method
viabl
clinic
applic
clinic
specimen
pediatr
patient
clinic
diagnos
mild
sever
hfmd
subject
sequenc
follow
hexanucleotid
primerbas
ng
procedur
viral
nucleic
acid
sampl
sampl
total
enrich
use
barcod
hexanucleotid
primer
revers
transcript
doublestrand
cdna
synthesi
amplif
reaction
accomplish
librari
construct
two
sequenc
librari
contain
sampl
load
onto
two
chip
life
technolog
separ
sequenc
ion
torrent
pgm
raw
data
two
independ
sequenc
run
assign
back
origin
sampl
accord
differ
barcod
sequenc
total
number
read
sampl
rang
mean
read
length
vari
bp
bp
tabl
read
origin
sampl
use
directli
input
viru
identif
via
vip
result
show
mani
read
map
hfmdrelat
viral
pathogen
figur
eight
sampl
identifi
coxsackieviru
three
sampl
identifi
coxsackieviru
one
sampl
identifi
coxsackieviru
anoth
one
identifi
ev
addit
remain
seven
clinic
specimen
identifi
hevneg
four
sampl
also
found
neg
realtim
rtpcr
analysi
show
sever
hfmdunrel
viral
pathogen
simultan
identifi
clinic
sampl
shown
figur
read
seven
sampl
assign
member
anellovirida
famili
contain
genera
two
sampl
sampl
sampl
found
torqu
data
obtain
viral
enrich
random
hexam
primer
revers
transcript
polymeras
chain
reaction
bdat
obtain
viral
enrich
nonribosom
hexanucleotid
primer
revers
transcript
polymeras
chain
reaction
teno
mini
viru
ttmv
relat
sequenc
two
sampl
sampl
sampl
found
ttmvand
torqu
teno
viru
ttv
relat
sequenc
singl
sampl
sampl
found
posit
ttmv
torqu
teno
like
midi
viru
ttmdv
anoth
two
sampl
sampl
sampl
found
posit
ttmv
ttv
ttmdv
notabl
clinic
specimen
contain
signific
number
read
coverag
refer
complet
genom
ttmv
figur
sampl
subsequ
confirm
posit
nest
rtpcr
use
univers
primer
pair
data
shown
interestingli
read
sever
sampl
assign
bluetongu
viru
human
herpesviru
clinic
specimen
clinic
specimen
found
sequenc
relat
three
human
herpesviru
type
notabl
clinic
specimen
clinic
specimen
test
posit
bluetongu
viru
coverag
gene
coverag
genom
latter
simultan
codetect
presenc
ttv
ttmv
ttmdv
coxsackieviru
probabl
sever
patient
clinic
specimen
infect
multipl
viral
pathogen
furthermor
worth
mention
clinic
specimen
found
posit
measl
viru
coverag
refer
complet
genom
figur
interest
part
sampl
diagnos
mild
hfmd
clinic
hfmdassoci
viral
pathogen
test
neg
realtim
rtpcr
tabl
sampl
subsequ
verifi
realtim
rtpcr
use
measl
virusspecif
primer
pair
mf
mr
ct
valu
complet
genom
sequenc
measl
viru
sinc
assembl
combin
ng
data
sanger
sequenc
data
laboratori
data
shown
meanwhil
complet
genom
sequenc
measl
viru
use
phylogenet
analysi
conduct
neighbourjoin
method
use
mega
softwar
bootstrap
valu
shown
figur
measl
viru
cluster
branch
phylogenet
tree
togeth
measl
viru
strain
genotyp
ng
becom
robust
tool
identifi
character
viral
pathogen
sampl
howev
sever
challeng
imped
widespread
adopt
ng
clinic
applic
studi
describ
improv
ng
approach
base
barcod
oligonucleotid
primer
demonstr
viabil
method
rapid
direct
identif
multipl
viral
pathogen
hmfdassoci
clinic
sampl
advantag
improv
ng
approach
firstli
procedur
librari
construct
simplifi
without
shear
step
brief
shown
common
whole
genom
sequenc
wg
viru
discoveri
base
cdna
amplifi
fragment
length
polymorph
vidisca
combin
ng
virocapcombin
ng
ng
protocol
librari
construct
usual
tediou
labori
time
consum
everi
sampl
must
process
individu
entir
workflow
contrast
improv
ng
protocol
everi
enrich
product
independ
sampl
pool
togeth
one
tube
mixtur
regard
singl
sampl
downstream
process
includ
endrepair
adapt
ligat
size
select
librari
quantiti
sequenc
figur
importantli
improv
ng
data
obtain
fragmentationfre
librari
may
conserv
natur
content
origin
sampl
reveal
factual
viral
pathogen
inform
artefactu
recombin
may
introduc
shear
librari
regardless
enzym
digest
sonic
system
use
librari
fragment
moreov
artifactu
recombin
ng
gener
sequenc
chimera
affect
ng
data
analysi
comput
pipelin
estim
nucleotid
polymorph
frequenc
speci
popul
divers
gener
incorrect
de
novo
genom
assembl
secondli
improv
ng
approach
greatli
time
save
labor
save
cost
effect
compar
convent
protocol
sampl
process
individu
throughout
ng
procedur
construct
fragment
sequenc
librari
alway
prefer
tremend
ng
data
analyz
depend
profession
bioinformatician
use
expens
hardwar
configur
commerci
softwar
improv
method
spent
time
cost
capit
process
sequenc
librari
origin
independ
sampl
furthermor
ng
data
analysi
use
inhous
vip
save
time
cost
vip
need
minimum
hardwar
configur
run
common
desktop
person
comput
ghz
intel
core
gb
ram
run
ubuntu
lt
easili
manipul
someon
without
background
bioinformat
notabl
practic
applic
vip
util
analyz
ng
data
one
unknown
sampl
sever
dengu
outbreak
guangzhou
demonstr
vip
contribut
time
viru
diagnosi
min
allow
detail
viru
inform
obtain
acut
ill
patient
potenti
perform
unbias
ngsbase
clinic
studi
demand
short
turnaround
time
gener
improv
approach
took
approxim
h
viral
pathogen
analysi
sampl
compris
h
rna
extract
h
viral
enrich
h
librari
construct
h
emuls
pcr
es
sequenc
h
data
analysi
therefor
improv
ng
approach
combin
inhous
vip
suitabl
rapid
identif
viral
pathogen
clinic
applic
especi
emerg
viral
outbreak
mani
sampl
await
detect
initi
model
experi
improv
ng
approach
adopt
compar
viral
enrich
abil
random
hexam
nonribosom
hexanucleotid
revers
transcript
follow
pcr
sequenc
use
differ
sampl
contain
known
virus
differ
viral
load
data
one
ebv
sampl
flu
b
sampl
three
differ
viral
load
one
sampl
show
hexanucleotid
compar
tradit
random
hexam
sequenc
perform
ebv
flu
b
high
viral
load
ct
valu
read
ebv
flu
b
cover
nearli
complet
sequenc
ebv
membran
protein
flu
b
segment
tabl
contrari
random
hexam
slightli
inferior
hexanucleotid
coverag
complet
genom
flu
b
segment
sampl
low
viral
load
ct
valu
flub
respect
result
indic
sequenceindepend
amplif
barcod
oligonucleotid
primer
combin
improv
ng
approach
work
effici
directli
detect
viral
pathogen
cell
cultur
materi
clinic
specimen
moreov
rna
viral
sampl
ratio
virusrel
read
origin
hexanucleotideenrich
sampl
higher
origin
random
hexamerenrich
sampl
tabl
consist
result
endoh
et
al
use
rda
method
suggest
ngsbase
sequenceindepend
amplif
hexanucleotid
reduc
nois
compar
random
hexam
remark
improv
ngsbase
sequenceindepend
amplif
hexanucleotid
suitabl
detect
viral
pathogen
cell
cultur
materi
also
clinic
specimen
low
viral
load
previous
report
rdabas
sequenceindepend
amplif
hexanucleotid
might
restrict
infect
cell
contain
mani
copi
viru
first
report
simultan
compar
viral
enrich
abil
random
hexam
hexanucleotid
improv
ng
platform
furthermor
use
sequenceindepend
amplif
hexanucleotid
follow
improv
ng
approach
realtim
rtpcr
simultan
detect
clinic
specimen
pediatr
patient
clinic
diagnos
mild
sever
hfmd
present
studi
total
posit
rate
hfmdassoci
viral
pathogen
identifi
ng
wherea
sampl
detect
realtim
rtpcr
includ
sampl
miss
ng
notabl
viral
pathogen
detect
hfmd
clinic
specimen
detail
type
coxsackieviru
coxsackieviru
coxsackieviru
ev
via
improv
ng
method
wherea
sampl
except
ev
classifi
hev
without
type
inform
realtim
rtpcr
thu
improv
ng
method
may
play
import
role
accur
identif
provid
detail
subtyp
serotyp
inform
viral
pathogen
meanwhil
result
show
correl
amount
viral
rna
realtim
rtpcr
sequenc
read
ng
approach
particularli
strong
coxsackieviru
sampl
decreas
ct
valu
correl
increas
sequenc
read
suggest
sequenc
read
might
suitabl
indic
viral
load
test
sampl
besid
promin
advantag
ng
approach
includ
improv
one
mention
provid
comprehens
inform
sampl
ng
data
twenti
clinic
specimen
show
sampl
contain
bacteria
bacteriophag
host
inform
data
shown
viral
pathogen
unrecogn
specif
realtim
rtpcr
apart
hfmdassoci
virus
instanc
viral
coinfect
detect
ng
though
viral
sequenc
captur
enough
identif
ttv
ttmv
ttmdv
bluetongu
viru
human
herpesviru
hfmdposit
sampl
interestingli
ttv
ttmv
ttmdv
also
wide
found
diseas
especi
viral
hepat
asthma
sever
lower
respiratori
tract
infect
ttv
ttmv
singl
dual
infect
found
two
sampl
mild
hfmd
ttv
ttmv
ttmdv
singl
dual
tripl
infect
found
five
sampl
sever
hfmd
littl
evid
associ
infect
ttv
ttmv
ttmdv
hfmd
specul
ttv
ttmv
ttmdv
might
respons
caus
sever
hfmd
exacerb
diseas
progress
addit
clinic
specimen
initi
diagnos
mild
hfmd
clinic
later
test
hev
neg
via
realtim
rtpcr
found
measl
viru
posit
use
ng
even
though
read
assign
measl
viru
appear
low
cover
complet
refer
genom
suspect
case
probabl
misdiagnos
clinician
one
clinic
characterist
measl
patient
maculopapular
rash
similar
vesicular
rash
caus
hfmd
thu
difficult
differenti
measl
hfmd
earli
onset
moreov
measl
case
success
valid
via
realtim
rtpcr
confirm
recheck
medic
record
clinic
diagnos
measl
month
later
therefor
ng
analysi
studi
demonstr
misdiagnos
hfmd
occur
clinic
nevertheless
similar
previou
studi
shortcom
improv
ng
approach
low
sensit
respect
agentspecif
realtim
rtpcr
assay
improv
ng
approach
less
sensit
realtim
rtpcr
assay
sampl
ct
detect
wherea
one
ct
miss
agreement
thorburn
et
al
state
ng
method
may
cutoff
region
ct
furthermor
averag
depth
sequenc
clinic
sampl
low
viral
load
rang
far
less
sampl
high
viral
content
rang
lecuit
et
al
show
sensit
deepsequenc
approach
detect
virus
depend
sequenc
depth
probabl
rel
low
sensit
improv
ng
approach
attribut
low
sequenc
depth
ultralow
viral
content
clinic
specimen
address
problem
adopt
higher
throughput
method
probabl
increas
viral
detect
rate
use
chip
replac
chip
select
greater
capac
sequenc
platform
illumina
miseq
ion
conclus
improv
ng
approach
simplifi
rapid
rel
costeffect
method
could
use
simultan
identif
multipl
viral
pathogen
sampl
includ
cell
cultur
materi
clinic
specimen
provid
detail
type
inform
specif
viral
pathogen
well
differenti
misdiagnosi
event
appear
clinic
xjm
kn
chw
conceiv
idea
design
studi
chw
conduct
experi
sxq
collect
provid
hfmd
clinic
specimen
pediatr
patient
sfz
xnl
hyz
provid
primer
probe
hfmdassoci
viral
pathogen
detect
preserv
hfmd
clinic
specimen
chw
xjm
kn
yz
jw
analyz
ng
data
chw
wrote
manuscript
prepar
tabl
figur
xjm
review
manuscript
author
approv
manuscript
